Sagimet Biosciences (SGMT) Cash from Investing Activities: 2023-2024
Historic Cash from Investing Activities for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $624,000.
- Sagimet Biosciences' Cash from Investing Activities was N/A to $624,000 in Q3 2024 from the same period last year, while for Sep 2024 it was -$91.2 million, marking a year-over-year change of. This contributed to the annual value of -$61.7 million for FY2024, which is 590.33% down from last year.
- As of Q3 2024, Sagimet Biosciences' Cash from Investing Activities stood at $624,000, which was up 100.83% from -$75.2 million recorded in Q2 2024.
- Sagimet Biosciences' 5-year Cash from Investing Activities high stood at $19.4 million for Q1 2023, and its period low was -$75.2 million during Q2 2024.
- In the last 2 years, Sagimet Biosciences' Cash from Investing Activities had a median value of $1.8 million in 2024 and averaged -$9.8 million.
- Data for Sagimet Biosciences' Cash from Investing Activities shows a maximum YoY slumped of 687.16% (in 2024) over the last 5 years.
- Over the past 2 years, Sagimet Biosciences' Cash from Investing Activities (Quarterly) stood at -$19.6 million in 2023, then plummeted by 687.16% to $624,000 in 2024.
- Its last three reported values are $624,000 in Q3 2024, -$75.2 million for Q2 2024, and $3.0 million during Q1 2024.